Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)
CNY 9.6
(0.0%)
CNY 9.6
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.08 Billion CNY | 5.44% |
| 2022 | 2.92 Billion CNY | 8.05% |
| 2021 | 2.7 Billion CNY | 20.59% |
| 2020 | 2.24 Billion CNY | 12.42% |
| 2019 | 1.99 Billion CNY | 21.45% |
| 2018 | 1.64 Billion CNY | 19.65% |
| 2017 | 1.37 Billion CNY | 8.02% |
| 2016 | 1.27 Billion CNY | 19.16% |
| 2015 | 1.06 Billion CNY | 14.89% |
| 2014 | 928.42 Million CNY | 99.09% |
| 2013 | 466.34 Million CNY | 24.09% |
| 2012 | 375.81 Million CNY | 14.79% |
| 2011 | 327.38 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 3.28 Billion CNY | 1.83% |
| 2024 Q2 | 3.22 Billion CNY | -0.82% |
| 2024 Q1 | 3.25 Billion CNY | 5.61% |
| 2023 Q3 | 3.1 Billion CNY | 2.08% |
| 2023 Q4 | 3.08 Billion CNY | -0.76% |
| 2023 Q1 | 2.98 Billion CNY | 2.09% |
| 2023 Q2 | 3.04 Billion CNY | 1.95% |
| 2023 FY | 3.08 Billion CNY | 5.44% |
| 2022 Q4 | 2.92 Billion CNY | 12.7% |
| 2022 Q3 | 2.59 Billion CNY | -17.26% |
| 2022 Q2 | 3.13 Billion CNY | 9.83% |
| 2022 Q1 | 2.85 Billion CNY | 5.5% |
| 2022 FY | 2.92 Billion CNY | 8.05% |
| 2021 Q4 | 2.7 Billion CNY | 4.59% |
| 2021 Q2 | 2.4 Billion CNY | 6.93% |
| 2021 Q3 | 2.58 Billion CNY | 7.3% |
| 2021 FY | 2.7 Billion CNY | 20.59% |
| 2021 Q1 | 2.25 Billion CNY | 0.49% |
| 2020 Q1 | 2.07 Billion CNY | 3.95% |
| 2020 Q2 | 1.99 Billion CNY | -3.7% |
| 2020 Q3 | 2.06 Billion CNY | 3.37% |
| 2020 Q4 | 2.24 Billion CNY | 8.64% |
| 2020 FY | 2.24 Billion CNY | 12.42% |
| 2019 Q3 | 1.91 Billion CNY | 4.66% |
| 2019 Q2 | 1.82 Billion CNY | 8.65% |
| 2019 Q4 | 1.99 Billion CNY | 4.36% |
| 2019 FY | 1.99 Billion CNY | 21.45% |
| 2019 Q1 | 1.68 Billion CNY | 2.34% |
| 2018 Q1 | 1.41 Billion CNY | 2.78% |
| 2018 FY | 1.64 Billion CNY | 19.65% |
| 2018 Q4 | 1.64 Billion CNY | -1.7% |
| 2018 Q3 | 1.67 Billion CNY | 9.1% |
| 2018 Q2 | 1.53 Billion CNY | 8.55% |
| 2017 Q4 | 1.37 Billion CNY | -6.27% |
| 2017 Q1 | 1.29 Billion CNY | 1.81% |
| 2017 Q3 | 1.46 Billion CNY | 9.95% |
| 2017 FY | 1.37 Billion CNY | 8.02% |
| 2017 Q2 | 1.33 Billion CNY | 2.95% |
| 2016 Q1 | 1.06 Billion CNY | -0.54% |
| 2016 FY | 1.27 Billion CNY | 19.16% |
| 2016 Q3 | 1.13 Billion CNY | 1.74% |
| 2016 Q2 | 1.11 Billion CNY | 4.94% |
| 2016 Q4 | 1.27 Billion CNY | 12.22% |
| 2015 Q2 | 972.92 Million CNY | 2.8% |
| 2015 Q1 | 946.37 Million CNY | 1.93% |
| 2015 Q4 | 1.06 Billion CNY | 8.03% |
| 2015 FY | 1.06 Billion CNY | 14.89% |
| 2015 Q3 | 987.41 Million CNY | 1.49% |
| 2014 Q2 | 500.89 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q3 | 530.3 Million CNY | 5.87% |
| 2014 Q4 | 928.42 Million CNY | 75.07% |
| 2014 FY | 928.42 Million CNY | 99.09% |
| 2013 FY | 466.34 Million CNY | 24.09% |
| 2013 Q4 | 466.34 Million CNY | 0.0% |
| 2012 FY | 375.81 Million CNY | 14.79% |
| 2011 FY | 327.38 Million CNY | 0.0% |